Optiscan Imaging Ltd
ASX:OIL
Optiscan Imaging Ltd
Revenue
Optiscan Imaging Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Revenue
AU$1.3m
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
31%
|
|
|
Somnomed Ltd
ASX:SOM
|
Revenue
AU$100.3m
|
CAGR 3-Years
15%
|
CAGR 5-Years
10%
|
CAGR 10-Years
11%
|
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Revenue
AU$27.6m
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
9%
|
|
|
Cochlear Ltd
ASX:COH
|
Revenue
AU$2.3B
|
CAGR 3-Years
14%
|
CAGR 5-Years
9%
|
CAGR 10-Years
10%
|
|
|
Austco Healthcare Ltd
ASX:AHC
|
Revenue
AU$58.2m
|
CAGR 3-Years
21%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Revenue
AU$8.6m
|
CAGR 3-Years
76%
|
CAGR 5-Years
56%
|
CAGR 10-Years
N/A
|
|
Optiscan Imaging Ltd
Glance View
Optiscan Imaging Ltd. is engaged in the development of endomicroscopic imaging technologies for medical, translational and pre-clinical applications. The company is headquartered in Mulgrave, Victoria. The firm has developed and commercialized confocal microscopes for clinical and pre-clinical applications. Its endomicroscopic technology enables 3D, in-vivo imaging of human tissue at the cellular level for cancer screening, diagnoses and in surgery. Its InVivage device is developed for clinical use in the oral cancer and other cancer applications. Its Fluorescence In Vivo Endomicroscopy (FIVE2) also known as ViewnVivo system, is a miniaturised confocal endomicroscope used for cellular level in-vivo imaging in living tissues. The firm also provides customization options for its product, (FIVE2).
See Also
What is Optiscan Imaging Ltd's Revenue?
Revenue
1.3m
AUD
Based on the financial report for Dec 31, 2024, Optiscan Imaging Ltd's Revenue amounts to 1.3m AUD.
What is Optiscan Imaging Ltd's Revenue growth rate?
Revenue CAGR 10Y
31%
Over the last year, the Revenue growth was -23%. The average annual Revenue growth rates for Optiscan Imaging Ltd have been 13% over the past three years , 9% over the past five years , and 31% over the past ten years .
You don't have any saved screeners yet